GleamWall
中文EN

INSP Inspire Medical Systems, Inc.

Surgical & Medical Instruments & Apparatus · NYSE · SEC CIK 1609550 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-0.2%
TTM net income YoY126.0%
TTM EPS YoY129.5%
Revenue 3-yr CAGR15.6%
Net income 3-yr CAGR—

Margins

Gross margin86.2%
Operating margin1.8%
Net margin11.4%
FCF margin11.1%
EBITDA margin3.9%

Returns

ROE13.5%
ROA11.4%
ROIC (approx.)2.6%
Asset turnover1.00x

Leverage & solvency

Liabilities / assets13.2%
Debt / equity0.00x
Current ratio6.45x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.34x
Accruals ratio-3.9%
Payout ratio—
Capex / revenue4.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$206.69M$200.58M$204.58M$269.08M$224.50M$217.09M$201.32M$239.72M
Cost of revenue$28.84M$29.12M$27.67M$36.07M$31.77M$34.67M$30.71M$35.99M
Gross profit$177.86M$171.46M$176.91M$233.01M$192.73M$182.41M$170.61M$203.73M
R&D expense$22.18M$24.70M$25.83M$24.94M$24.21M$26.21M$27.80M$30.34M
SG&A expense$184.40M$147.28M$152.20M$161.95M$158.87M$159.52M$144.29M$141.51M
Operating income-$28.72M-$514,000-$1.12M$46.11M$9.64M-$3.32M-$1.49M$31.88M
Interest expense———$122,000$11,000$4,000—$22,000
Pretax income-$25.01M$3.12M$2.40M$50.32M$13.55M-$2.33M$4.16M$36.64M
Income tax-$616,000$2.80M$13.69M-$85.77M$3.62M$1.26M$1.17M$1.41M
Net income-$24.39M$314,000-$11.29M$136.09M$9.93M-$3.59M$2.99M$35.22M
EBITDA-$23.62M$4.09M$3.99M$49.93M$13.34M$84,000$1.56M$34.36M
EPS (basic)-0.840.01-0.39—0.34-0.120.10—
EPS (diluted)-0.840.01-0.39—0.34-0.120.10—
Weighted avg. shares (diluted)28.93M28.94M28.70M—29.60M29.51M30.31M—
Balance sheet
Cash & equivalents$190.80M$127.76M$98.93M$104.81M$112.84M$106.93M$53.88M$150.15M
Short-term investments$137.17M$192.92M$184.90M$203.46M$209.75M$193.97M$315.31M$295.40M
Receivables$104.71M$103.34M$105.09M$119.69M$107.99M$137.69M$92.63M$93.07M
Inventory$178.96M$170.45M$166.24M$145.29M$141.78M$121.63M$99.73M$80.12M
Current assets$627.62M$608.67M$566.82M$583.65M$586.49M$573.19M$571.68M$630.81M
PP&E, net$85.64M$104.33M$100.69M$97.87M$91.51M$85.27M$77.17M$71.92M
Total assets$953.03M$925.99M$911.38M$907.32M$807.72M$802.19M$730.81M$808.38M
Current liabilities$97.34M$71.18M$89.42M$96.06M$110.84M$93.36M$63.47M$88.50M
Total liabilities$126.08M$100.41M$119.04M$126.16M$141.26M$124.38M$95.07M$118.69M
Shareholders' equity$826.95M$825.58M$792.34M$781.16M$666.46M$677.81M$635.74M$689.70M
Shares outstanding28.94M28.91M28.80M28.58M29.05M29.57M29.47M29.74M
Cash flow statement
Operating cash flow$46.43M$23.23M$12.85M$52.47M$68.53M$2.68M-$6.70M$69.18M
Capital expenditure$7.54M$9.16M$9.73M$10.66M$10.44M$9.00M$8.41M$7.03M
Free cash flow$38.88M$14.07M$3.12M$41.81M$58.09M-$6.31M-$15.11M$62.15M
Investing cash flow$17.05M$3.55M-$11.25M-$11.92M-$11.64M$46.56M-$1.55M$3.76M
Financing cash flow-$436,000$1.91M-$7.48M-$48.31M-$51.08M$3.70M-$87.76M-$70.14M
Depreciation & amortization$5.10M$4.60M$5.11M$3.82M$3.70M$3.40M$3.04M$2.48M
Stock-based compensation$26.90M$31.20M$30.69M$28.01M$29.50M$41.70M$31.06M$29.14M
Share buybacks$0$0$0$50.01M$50.00M$0$75.01M$75.00M

Free plan shows the latest 8 periods; Pro shows all 39 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.